SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328901. A total of 3 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $993,000 | -65.9% | 4,053 | -0.6% | 0.04% | -63.4% |
| Q3 2014 | $2,912,000 | +17.4% | 4,079 | +7.3% | 0.11% | +5.7% |
| Q2 2014 | $2,480,000 | +19.5% | 3,803 | +21.2% | 0.11% | -8.6% |
| Q1 2014 | $2,075,000 | +208.8% | 3,139 | +121.4% | 0.12% | +169.8% |
| Q4 2013 | $672,000 | – | 1,418 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,803 | $2,480,000 | 0.11% |
| GROUP ONE TRADING, L.P. | 65,200 | $425,000 | 0.01% |
| Citadel Advisors | 25,100 | $164,000 | 0.00% |